IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 317 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $276,000 | +30.8% | 3,400 | -12.8% | 0.00% | 0.0% |
| Q4 2018 | $211,000 | +5.0% | 3,900 | 0.0% | 0.00% | +33.3% |
| Q3 2018 | $201,000 | -46.4% | 3,900 | -56.7% | 0.00% | -50.0% |
| Q2 2018 | $375,000 | +37.4% | 9,000 | +45.2% | 0.01% | +20.0% |
| Q1 2018 | $273,000 | -2.5% | 6,200 | +11.5% | 0.01% | 0.0% |
| Q4 2017 | $280,000 | +0.4% | 5,563 | +1.1% | 0.01% | 0.0% |
| Q3 2017 | $279,000 | -0.4% | 5,500 | 0.0% | 0.01% | -16.7% |
| Q2 2017 | $280,000 | +7.3% | 5,500 | -15.4% | 0.01% | +20.0% |
| Q1 2017 | $261,000 | -16.1% | 6,500 | 0.0% | 0.01% | -28.6% |
| Q4 2016 | $311,000 | +44.0% | 6,500 | +10.2% | 0.01% | +40.0% |
| Q3 2016 | $216,000 | -9.6% | 5,900 | 0.0% | 0.01% | -16.7% |
| Q1 2016 | $239,000 | -34.5% | 5,900 | 0.0% | 0.01% | -33.3% |
| Q4 2015 | $365,000 | – | 5,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |